Artificial intelligence (AI) can rapidly screen patients for clinical trial enrollment, according to a study published in JAMA and led by Mass General Brigham researchers. Their novel AI-assisted patient screening tool significantly improved the speed of determining eligibility and enrollment in a heart failure clinical trial compared to manual screening.
AI screening for heart failure clinical trial speeds up enrollment, study finds
